| This article has been cited by |
| 1 | | |
| Roger Luechinger |
| .2023;()39 |
| [DOI] |
|
| 2 | Adverse effects of drugs on the kidney | |
| Ettore Bartoli |
| European Journal of Internal Medicine.2016;28()1 |
| [DOI] |
|
| 3 | Cardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population | |
| Frances M Mitchell |
| World Journal of Clinical Pediatrics.2016;5(1)1 |
| [DOI] |
|
| 4 | Cardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population | |
| Frances M Mitchell |
| World Journal of Clinical Pediatrics.2017;5(1)220 |
| [DOI] |
|
| 5 | Enhancing the Imaging and Biosafety of Upconversion Nanoparticles through Phosphonate Coating | |
| Ruibin Li,Zhaoxia Ji,Juyao Dong,Chong Hyun Chang,Xiang Wang,Bingbing Sun,Meiying Wang,Yu-Pei Liao,Jeffrey I. Zink,Andre E. Nel,Tian Xia |
| ACS Nano.2015;9(3)3293 |
| [DOI] |
|
| 6 | Safety and technique of ferumoxytol administration for MRI | |
| Shreyas S. Vasanawala,Kim-Lien Nguyen,Michael D. Hope,Mellena D. Bridges,Thomas A. Hope,Scott B. Reeder,Mustafa R. Bashir |
| Magnetic Resonance in Medicine.2016;75(5)2107 |
| [DOI] |
|
| 7 | Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists | |
| Nicola Schieda,Jason I. Blaichman,Andreu F. Costa,Rafael Glikstein,Casey Hurrell,Matthew James,Pejman Jabehdar Maralani,Wael Shabana,An Tang,Anne Tsampalieros,Christian B. van der Pol,Swapnil Hiremath |
| Canadian Journal of Kidney Health and Disease.2018;5(5)205435811877857 |
| [DOI] |
|
| 8 | Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study | |
| Philippe Soyer,Anthony Dohan,Deepak Patkar,Andreas Gottschalk |
| Journal of Magnetic Resonance Imaging.2017;45(4)988 |
| [DOI] |
|
| 9 | Half-dose gadoxetic acid-enhanced liver magnetic resonance imaging in patients at risk for nephrogenic systemic fibrosis | |
| Kyoung Doo Song,Seong Hyun Kim,Jisun Lee,Kyung A. Kang,Joungyoun Kim,Heejin Yoo |
| European Journal of Radiology.2015;84(3)378 |
| [DOI] |
|
| 10 | Stealth Rare Earth Oxide Nanodiscs for Magnetic Resonance Imaging | |
| Mark J. Bailey,Rob van der Weegen,Piper J. Klemm,Suzanne L. Baker,Brett A. Helms |
| Advanced Healthcare Materials.2012;1(4)437 |
| [DOI] |
|
| 11 | Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance | |
| Theresa Reiter,Oliver Ritter,Martin R Prince,Peter Nordbeck,Christoph Wanner,Eike Nagel,Wolfgang Rudolf Bauer |
| Journal of Cardiovascular Magnetic Resonance.2012;14(1)437 |
| [DOI] |
|
| 12 | Gadolinium and nephrogenic systemic fibrosis: an update | |
| Alex Weller,Joy L Barber,Øystein E Olsen |
| Pediatric Nephrology.2014;29(10)1927 |
| [DOI] |
|
| 13 | Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists | |
| Nicola Schieda,Jason I. Blaichman,Andreu F. Costa,Rafael Glikstein,Casey Hurrell,Matthew James,Pejman Jabehdar Maralani,Wael Shabana,An Tang,Anne Tsampalieros,Christian van der Pol,Swapnil Hiremath |
| Canadian Association of Radiologists Journal.2018;69(2)136 |
| [DOI] |
|
| 14 | Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study) | |
| Gilbert Deray,Olivier Rouviere,Lorenzo Bacigalupo,Bart Maes,Thierry Hannedouche,François Vrtovsnik,Claire Rigothier,Jean-Marie Billiouw,Paolo Campioni,Joaquin Ferreiros,Daniel Devos,Daniel Alison,François Glowacki,Jean-Jacques Boffa,Luis Marti-Bonmati |
| European Radiology.2013;23(5)1250 |
| [DOI] |
|
| 15 | Preclinical Evaluation of a Protein-Based Nanoscale Contrast Agent for MR Angiography at an Ultralow Dose | |
| Jianmin Li,Wenyi Zhang,Shuang Liu,Fan Yang,Yupeng Zhou,Lin Cao,Yiming Li,Yunfei Guo,Xiang Qi,Guoping Xu,Jing Peng,Yang Zhao |
| International Journal of Nanomedicine.2023;Volume 18(5)4431 |
| [DOI] |
|
| 16 | Nephrogenic Systemic Fibrosis Risk and Liver Disease | |
| Robert F. Hanna,Lee A. Finkelstone,Daniel S. Chow,Vesselin Z. Miloushev,Mark R. Escudero,Stephen M. Lagana,Martin R. Prince |
| International Journal of Nephrology.2014;2014(5)1 |
| [DOI] |
|
| 17 | Historical Perspective of Imaging Contrast Agents | |
| Carlos A. Zamora,Mauricio Castillo |
| Magnetic Resonance Imaging Clinics of North America.2017;25(4)685 |
| [DOI] |
|
| 18 | Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents | |
| Emmanuil Smorodinsky,David S. Ansdell,Zeke W. Foster,Sameer M. Mazhar,Irene Cruite,Tanya Wolfson,Sebastian B. Sugay,Gabriella Iussich,Masoud Shiehmorteza,Yuko Kono,Alexander Kuo,Claude B. Sirlin |
| Journal of Magnetic Resonance Imaging.2015;41(5)1259 |
| [DOI] |
|
| 19 | Analysis of Lanthanide Complex Dendrimer Conjugates for Bimodal NIR and MRI Imaging | |
| Christopher M. Andolina,Piper J. Klemm,William C. Floyd,Jean M. J. Fréchet,Kenneth N. Raymond |
| Macromolecules.2012;45(22)8982 |
| [DOI] |
|
| 20 | Recomendaciones de buenas prácticas en urorradiología pediátrica | |
| P.-H. Vivier,M. Dolores,J. Le Cloirec,E. Blondiaux,M. Beurdeley,A. Liard,F. Elbaz,J.-N. Dacher |
| EMC - Urología.2016;48(1)1 |
| [DOI] |
|
